Torthaí cuardaigh - Pascal Maisonobe

  • 1 - 15 toradh as 15 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management

    Results from the Upper Limb International Spasticity Study-II (ULIS-II): a large, international, prospective cohort study investigating practice and goal attainment following treat... de réir Lynne Turner‐Stokes, Klemens Fheodoroff, Jorge Jacinto, Pascal Maisonobe

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice

    Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment foll... de réir Lynne Turner‐Stokes, Klemens Fheodoroff, Jorge Jacinto, Pascal Maisonobe, Benjamin Zakine

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study

    Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study de réir V.P. Misra, Edvard Ehler, Benjamin Zakine, Pascal Maisonobe, M. Simonetta‐Moreau

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Control of IGF‐I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly

    Control of IGF‐I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly de réir Philippe Chanson, Françoise Borson‐Chazot, Jean‐Marc Kuhn, Joëlle Blumberg, Pascal Maisonobe, Brigitte Delemer

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin

    INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin de réir V.P. Misra, Carlo Colosimo, David Charles, Tae Mo Chung, Pascal Maisonobe, Savary Om

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice

    Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice de réir Richard D. Zorowitz, Jorge Jacinto, Stephen Ashford, Mathieu Beneteau, Pascal Maisonobe, Christian Hannes, Alberto Esquenazi

    Foilsithe / Cruthaithe 2025
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial

    Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial de réir Philippe Caron, John S. Bevan, Stephan Petersenn, Daniel Flanagan, Antoine Tabarin, Gaëtan Prévost, Pascal Maisonobe, Antoine Clermont

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

    Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase... de réir Pascale Mariani, Joëlle Blumberg, Alain Landau, Daniela Lebrun-Jezekova, Estelle Botton, Olivier Béatrix, Didier Mayeur, Robert Hervé, Pascal Maisonobe, L. Chauvenet

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case–Control Study

    Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case–Control Study de réir Charles Chapron, Jinghe Lang, Jinhua Leng, Yingfang Zhou, Xinmei Zhang, Min Xue, А. А. Попов, Vladimir Romanov, Pascal Maisonobe, Patrick Cabri

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study

    Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study de réir Philippe Ruszniewski, Juan W. Valle, Catherine Lombard‐Bohas, Daniel J. Cuthbertson, Petros Perros, L Holubec, Gianfranco Delle Fave, Denis Smith, Patricia Niccoli, Pascal Maisonobe, Philippe Atlan, Martyn Caplin

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study

    Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study de réir Sebastian JCMM Neggers, Vyacheslav Pronin, Inga Balcere, Moon‐Kyu Lee, Liudmila Rozhinskaya, Marcello D. Bronstein, Mônica R. Gadelha, Pascal Maisonobe, Caroline Sert, Aart Jan van der Lely, NULL AUTHOR_ID

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study

    Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study de réir Raymond L. Rosales, Jovita Balcaitiene, Hugues Berard, Pascal Maisonobe, Khean Jin Goh, Witsanu Kumthornthip, Mazlina Mazlan, Lydia Abdul Latif, Mary Mildred Delgado-Delos Santos, Chayaporn Chotiyarnwong, Phakamas Tanvijit, Odessa Setiota Nuez, Keng He Kong

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study

    Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II st... de réir Marta Martín-Richard, Bartomeu Massutí, Eva Margarita Pineda, Vicente Alonso, Maribel Mármol, Daniel Castellano, Emilio Fonseca, António Galán de Mera, Marta Llanos, María Ángeles Sala, Carles Pericay, Fernando Rivera, Javier Sastre, Ángel Segura, María Quindós, Pascal Maisonobe

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study

    The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective B... de réir Patricia Khan, Marcelo Riberto, João Amaury Frances, Regina Helena Morganti Fornari Chueire, Ana Cristina Ferreira Garcia, Denise Rodrigues Xerez, Tae Mo Chung, Lucia Helena Costa Mercuri, Alexandre Luiz Longo, Sérgio Lianza, Pascal Maisonobe, Viviane C. Ruiz-Schutz

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults

    Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults de réir Marcelo Riberto, João Amaury Frances, Regina Helena Morganti Fornari Chueire, Ana Cristina Ferreira Garcia, Denise Rodrigues Xerez, Tae Mo Chung, Lucia Helena Costa Mercuri, Sérgio Lianza, Eduardo de Melo Carvalho Rocha, Pascal Maisonobe, Thais Cuperman-Pohl, Patricia Khan

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: